TITLE

Commentary

AUTHOR(S)
Rees, P. John
PUB. DATE
February 2006
SOURCE
Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p20
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article comments on a study by A. D. Smith and colleagues to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic asthma. This study was too small to evaluate exacerbations and had poor control.
ACCESSION #
20000928

 

Related Articles

  • Using exhaled NO concentrations to adjust inhaled corticosteroid dose maintained asthma control and reduced the dose. Smith, A. D.; Cowan, J. O.; Brassett, K. P.; Taylor, R. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p20 

    The article reports on a study to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic asthma. Patients aged 12-75...

  • Inhaled corticosteroids and COPD. Farquhar, Donald // CMAJ: Canadian Medical Association Journal;8/08/2000, Vol. 163 Issue 3, p326 

    Reports on a study of the effect of inhaled corticosteroid therapy as a treatment for chronic obstructive pulmonary disease (COPD). Use of the therapy on patients with asthma; Design; Results; Practice implications.

  • Potential Effects of Fluticasone Propionate on Bone Mineral Density in Patients With Asthma: A 2-Year Randomized, Double-Blind Placebo-Controlled Trial. Kemp, James P.; Osur, Scott; Shrewsbury, Stephen B.; Herje, Nancy E.; Duke, Susan P.; Harding, Stuart M.; Faulkner, Kennethf; Crim, Courtney C. // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p458 

    • Objective: To evaluate the effects of treatment with fluticasone propionate vs placebo on bone, hypothalamicpituitary-adrenal (HPA) axis function, and the eyes in patients with asthma. • Patients and Methods: This randomized, double-blind, placebo-controlled study of 160 patients...

  • Review: Hospital-at-home care does not increase mortality or readmission rates in acute exacerbations of COPD: COMMENTARY. Jacobs, Michael B. // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p59 

    Chronic obstructive pulmonary disease (COPD) is a common illness that is costly to treat, especially when hospitalization is required for acute exacerbations. Total estimated costs in 1993 in the United States were $24 billion; 60% of these costs were directly related to hospital-based care....

  • Review: Methylxanthines are not effective for acute exacerbations of chronic obstructive pulmonary disease.  // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p60 

    This article determines the effectiveness of addition of methylxanthines to standard treatments of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). Studies were selected if they were randomized controlled trials that compared methylxanthines with placebo for...

  • Inhaled corticosteroid use in patients with COPD or asthma. Kirchner, Jeffrey T. // American Family Physician;5/1/1997, Vol. 55 Issue 6, p2311 

    Focuses on the chart review conducted by Jackevicius and colleagues to determine the prevalence of inhaled corticosteroid used before and during hospitalization of patients with chronic obstructive pulmonary disease (COPD) or asthma. Methodology used in the study; Most commonly prescribed...

  • Does Inhaled Budesonide Produce Benefits in COPD? Walling, Anne D. // American Family Physician;11/1/1999, Vol. 60 Issue 7, p2156 

    Presents an evaluation on the treatment of chronic obstructive pulmonary disease (COPD) by inhaled corticosteroids. Long-term effects of inhaled budesonide in patients with COPD; Need for differentiation between asthma and COPD in patients with pulmonary symptoms.

  • Step One for Asthma Treatment: β-Agonists or Inhaled Corticosteroids? Redington, A.E. // Drugs;Jul2001, Vol. 61 Issue 9, p1231 

    Inhaled corticosteroids have proven effectiveness in chronic persistent asthma and are now recommended as first-line therapy in this condition. In contrast, long term preventative therapy is not currently considered necessary for patients with disease that is only mild and episodic. Recently,...

  • Qualitative assessment of attributes and ease of use of the ELLIPTATM dry powder inhaler for delivery of maintenance therapy for asthma and COPD. Svedsater, Henrik; Dale, Peter; Garrill, Karl; Walker, Richard; Woepse, Mark W. // BMC Pulmonary Medicine;2013, Vol. 13 Issue 1, p1 

    Background Medications for respiratory disorders including asthma and chronic obstructive pulmonary disease (COPD) are typically delivered to the lung by means of a handheld inhaler. Patient preference for and ability to use the inhaler may influence their adherence to maintenance therapy, and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics